LUCAT1 and neoplasm: Furthermore, a tumour initiation assay was performed to further evaluate the tumorigenicity capacity of BC cells in vivo, and knockdown of LUCAT1 in BC cells decreased the size (Fig. 3D), weight (Fig. 3E) and incidence (Fig. 3F and G) of xenografts.